Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Bioscience Reports, Vol. 25, Nos. 3/4, June/August 2005 ( 2005) DOI: 10.1007/s10540-005-2885-6 Adaptive Activation of Thyroid Hormone and Energy Expenditure Antonio C. Bianco,1,2 Ana Luiza Maia,1 Wagner Seixas da Silva,1 and Marcelo A. Christoffolete1 The mechanisms by which thyroid hormone accelerates energy expenditure are poorly understood. In the brown adipose tissue (BAT), activation of thyroid hormone by type 2 iodothyronine deiodinase (D2) has been known to play a role in adaptive energy expenditure during cold exposure in human newborns and other small mammals. Although BAT is not present in significant amounts in normal adult humans, recent studies have found substantial amounts of D2 in skeletal muscle, a metabolically relevant tissue in humans. This article reviews current biological knowledge about D2 and adaptive T3 production and their roles in energy expenditure. KEY WORDS: Deiodinase; brown adipose tissue; skeletal muscle; uncoupling protien. OVERVIEW In adults, the main biological effect of thyroid hormone is to accelerate energy expenditure, a paradigm that is based on observations made during experimental and clinical hypo- and hyperthyroidism [1]. In patients with severe hypothyroidism, total body energy expenditure can fall as much as ~50%, in thyrotoxic patients, it can be increased by ~50%, totaling an approximately threefold induction over hypothyroid baseline. However, given that serum levels of thyroid hormone are remarkably stable under normal conditions, it is not immediately apparent how thyroid hormone modifies energy expenditure under physiological conditions. Thyroxine (T4) is the main product of thyroid secretion. However, T4 is only a prohormone and must be activated by deiodination to T3 in order to initiate thyroid hormone action. This reaction is catalyzed by the type 1 and 2 iodothyronine deiodinases, D1 and D2 [2]. Because D2-generated T3 has a longer residence time than D2 within the cell [3], an advantage of this pathway is the possibility of 1 Thyroid Section, Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine Brigham and Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, HIM Bldg. #643, Massachusetts, Boston, MA, 02115, USA. 2 To whom correspondence should be addressed. E-mail: [email protected] 191 0144-8463/05/0800-0191/0 2005 Springer Science+Business Media, Inc. 192 Bianco, Maia, Silva, and Christoffolete controlling intracellular T3 concentration and thus T3-receptor (TR) saturation independently of serum T3. This allows for rapid, tissue-specific D2-mediated changes in intracellular thyroid status without affecting systemic thyroid hormone homeostasis. Perhaps, this is best illustrated by the essential role played by cochlear D2 in the early postnatal development of hearing. A transient isolated surge in D2 activity and local T3 production is critical not only for the onset of auditory function but also for the subsequent maturation of auditory sensitivity, without which severe hearing impairment develops [2]. In infants and other small mammals, energy expenditure is controlled by a surge in D2 that fully saturates TR in the brown adipose tissue (BAT), the main thermogenic site, thus creating a state of tissue-specific thyrotoxicosis. In the absence of the D2 induction mice develop hypothermia when exposed to cold, confirming the critical role of D2-dependent adaptive T3 production [2]. In addition, new evidence indicates that adaptive T3 production also plays a role in controlling energy expenditure in a number of mouse models of resistance to diet-induced obesity [4, 5]. However, adult humans lack substantial amounts of BAT and the major site for adaptive energy expenditure is skeletal muscle. It is thus quite striking that adult humans, unlike rodents, express D2 significantly in skeletal muscle [6, 7]. This has been implicated as a determinant of energy expenditure in adult humans [8–10], widening the interest in understanding endogenous, pharmacological, and environmental stimuli that potentially influence D2 expression. To understand the overall spectrum of thyroid hormone-related effects on energy homeostasis, it is important to define the major categories of energy expenditure. The metabolic rate (or rate of metabolism) is an essential feature of all earthly functioning things and is the sum total of all energy consumption or expenditure occurring in a system (machine, vegetal, or animal) at any given time. The minimum energy expenditure that allows normal function is called the basal metabolic rate (BMR). In animals the BMR is the energy expenditure necessary to sustain minimal homeostatic functions as measured at rest, in a 12-hour-fasted, fully relaxed subject kept at room temperature, It includes various forms of biological work, of which the major categories are (i) ionic and substrate cycles, particularly in the excitable tissues and kidney; (ii) metabolic cycles, particularly in the liver, muscle, and adipose tissue; (iii) muscle function, e.g., heart beats, respiratory movements, vasomotor tonus, and peristalsis; and (iv) basal secretion of exocrine glands and glands annex to the intestinal tract. The maintenance of the ATP pool that fuels BMR results in substantial heat production, which is known as obligatory thermogenesis. This is explained by the intrinsic thermodynamic inefficiency of energy transformation. In animals, this heat increases body temperature to one at which enzymatic reactions and biological functions operate optimally. In general, the higher the metabolic rate, the higher the body temperature. In turn, the higher the temperature, the higher the rates of chemical reactions, especially those catalyzed by enzymes. Two major biochemical processes explain heat production in living organisms: ATP synthesis and ATP hydrolysis (Fig. 1). The thermodynamic efficiency of the ATP synthesis is approximately 65%; i.e., approximately 35% of the energy released during the oxidation of energy substrates is lost as heat. Thus, most of the energy is transiently stored in the ATP molecule (ATP synthesis). Later, once the ATP Deiodination and Energy Expenditure 193 Fig. 1. Summary diagram of the energy-demanding pathways and heat release during ATP turnover. In this conceptualization, ATP hydrolysis leads to heat production. The ATP hydrolysis regenerates ADP and Pi, which serve as substrates for oxidative phosphorylation, to activate ATP production in the mitochondria. molecule is hydrolyzed to support biological work, more heat is lost. The thermodynamic efficiency of this second step is even lower––approximately 45%. Combined, the overall efficiency of mammals is approximately 25–30%. DEIODINASES ALLOW FOR TISSUE-SPECIFIC CONTROL OF THYROID HORMONE ACTION Given the generalized metabolic sensitivity to thyroid hormone documented during hypo- and hyperthyroidism, one would anticipate a major physiological role of this hormone in energy homeostasis. However, as mentioned above, serum T3 concentration is remarkably constant, thus precluding a major role of T3 in the BMR variations observed after a meal or during sleep. In the last 20 years, light was shed on this problem by studies demonstrating that in some tissues the cellular actions of thyroid hormone are determined not only by serum T3. Thyroid hormone action is initiated through its binding to nuclear receptors (TR), which are high-affinity nuclear T3 binding proteins that regulate transcription of T3-dependent genes. TR occupancy is determined by the affinity of the receptor for T3 and the T3 concentration in the nucleus. These values are such that, at normal serum T3 concentration, the contribution from serum T3 alone results in an approximately 50% saturation of TR in most tissues. However, tissues expressing D2 have an additional source of T3 contributed by the conversion of intracellular thyroxine (T4) to T3 [11, 12]. As a result, TR saturation can reach as high as 100%, with more than half of this T3 produced locally [13–15]. While we still do not understand all the intricacies of this system, we do know that generation of T3 by D2 occurs in the perinuclear region, a cellular compartment with preferential access to the nucleus. This is in contrast to D1, which is localized to the plasma membrane, from which the T3 produced more readily enters the plasma [16]. Thus, for cells lacking D2, intracellular thyroid status is determined predominantly by the serum T3 concentration. In contrast, cells expressing D2 have the ability to generate intracellular T3 from T4. This D2-generated T3, referred to as T3(T4), can also bind to nuclear receptors. Thus, cells expressing D2 have two potential sources of nuclear T3: plasma T3, or T3(T3), and T3(T4). On the other 194 Bianco, Maia, Silva, and Christoffolete hand, D3 has recently been found to be localized to the plasma membrane and to undergo recycling in the endosomes. Remarkably, D3 expression causes cell hypothyroidism as a result of its inactivating effect on thyroid hormone [17], thus creating a virtual barrier that prevents thyroid hormone from entering the cell nucleus. Thus, despite steady serum T3 levels, intracellular thyroid status varies along a wide range according to the type and level of deiodinase expression. TR saturation is expected to be minimum in cells expressing D3 and maximum in cells expressing D2 (Fig. 2). In addition, because of the plasticity of deiodinase expression, particularly that of D2, TR saturation of a single cell type might change rapidly and dramatically Fig. 2. Subcellular localization of the type 1, 2 ,and 3 selenodeiodinases and consequences on intracellular thyroid status. Confocal microscopy of cells treated with acetone-HEK-293 transiently expressing Dl-CF (panel a), D2-CF (panel b) and D3C-FLAG (panel c). After fixation and acetone treatment, cells were incubated with mouse anti-FLAG and anti-mouse-FITC (green). Panels a and b show a superimposition immunofluorescence images of the same fields costained with goat antiGRP78/BiP (endoplasmic reticulum specific marker) and anti-goat-rhodamine (red). Panel c shows a superimposition immunofluorescence image of the same fields costained with rabbit anti-FLAG and mouse anti- Na+/K+ -ATPase a, a typical plasma membrane marker; secondary antibodies were anti-rabbit IgG FITC and anti-mouse IgG Texas Red-X. Modified from [16, 90] . Deiodination and Energy Expenditure 195 without affecting serum T3. Thus, deiodinase expression in metabolically active tissues is a potent mechanism by which energy dissipation can be controlled. MORE HEAT––ADAPTIVE THERMOGENESIS Most of the time endothermic animals function at higher rates than the BMR because any activity that disrupts the resting state promotes ATP breakdown. In mammals, the metabolic rate can be increased by many factors, e.g., voluntary or involuntary physical activity, transference to a cold environment, hypercaloric feeding, and by fever. The heat derived from an increase in the metabolic rate is known as adaptive thermogenesis, which, as opposed to obligatory thermogenesis, may fluctuate rapidly in response to triggering signals, including thyroid hormone. This provides a tremendous evolutionary advantage that has allowed endothermic animals to live in and dominate virtually all planet environments [18 for review]. Exposure to cold prompts the hypothalamus to initiate a shivering response, the most important involuntary mechanism of cold-induced adaptive thermogenesis in adult humans and large mammals. However, shivering inevitably causes convective heat loss due to body oscillations and is therefore a less economical form of heat production than mitochondrial uncoupling, particularly in smaller organisms with a high surface to mass ratio. Thus, adaptive thermogenesis that does not involve shivering is the most important heat source in human newborns and other small mammals. This response is also initiated at the hypothalamus through the activation of the sympathetic nervous system (SNS), increasing the release of catecholamines throughout the body, particularly in the BAT, the key organ in adaptive thermogenesis. BAT is intensely innervated by the SNS, and its thermogenic capacity is largely due to uncoupling protein)1 (UCP1), a mitochondrial protein that shortcircuits the proton gradient across the inner mitochondrial membrane, bypassing the less abundant ATP synthase and thereby uncoupling fuel oxidation from the phosphorylation of ADP [19–21] (Fig. 3). The mediators of the SNS in the BAT involve a and b1)3 receptors, which act synergistically [22–25]. The resulting norepinephrine (NE)-induced increase in cAMP in brown adipocytes rapidly activates lipolysis, initiating mitochondrial heat production, and increases intracellular conversion of T4 to T3 via D2 by up to ~50-fold [22]––the human, rat and mouse Dio2 genes contain a highly functional canonical CREB-binding site in the promoter [26]. This transcriptional mechanism is potentiated by the prolongation of the half-life of D2. In addition, the adrenergic induction of a D2-binding protein, the pVHL-interacting deubiquitinating enzyme-1 (VDU1), catalyzes D2 deubiquitination and rescues it from proteasome degradation [27]. This increases the T3 concentration in BAT four- to five-fold within a few hours after cold exposure is initiated [28], creating an isolated thyrotoxicosis in the tissue [29]. As a result, the nucleus of brown adipocytes and other D2-containing cells has a higher T3 concentration and a higher saturation of the TRs––one that would cause thyrotoxicosis in most other tissues [30]. Using the dual-labeling technique, various investigators have found the level of TR saturation in brown adipocytes fluctuates primarily according to D2 activity and to plasma T3, the former being a major determinant of adaptive thermogenesis and survival in the cold [15, 29, 31]. As a result, the physiological changes that take place during cold and/or NE stimulation 196 Bianco, Maia, Silva, and Christoffolete Fig. 3. Mechanisms of D2-T3 generation in brown adipocytes. Brown adipocytes are stimulated by norepinephrine (NE) released from sympathetic terminals within the BAT. NE interacts with its receptors (AR) and activates adenylate cyclase (AC) through stimulatory G-protein, increasing intracellular cAMP levels. This activates triglyceride (TG) breakdown (lipolysis) and the expression of a series of cAMPdependent genes, namely UCP1, D2, and genes encoding proteins involved in the adrenergic signaling pathway. Intracellular T3 concentration increases as a result of D2 activation, and there is strong synergism between T3-dependent actions with cAMP-dependent actions towards an overall increase in energy expenditure and thermogenesis. Modified from [48]. Deiodination and Energy Expenditure 197 of BAT reflect a composite interaction between NE- and T3-generated signals that are linked in a feed-forward mechanism that leads to sustained heat liberation (Fig. 3). Blockade of D2-catalyzed conversion of T4 to T3 by iopanoic acid blocks the thermogenic response in T4-treated hypothyroid rats, indicating the essential role of this enzyme [32]. Brown adipocytes constitute a unique example of an intricate interaction between the thyroid and the SNS. Interscapular BAT of hypothyroid rats does not respond thermogenically to NE infusion, whereas BAT temperature in intact rats rapidly increases up to ~3 C [33]. This may be explained in part by mechanisms operating at the UCP1 gene, which is under tight control by NE and thyroid hormones. This has been studied extensively in vivo [31–37] and in freshly dispersed [38] and cultured brown adipocytes [39]. Cold exposure induces a rapid increase in UCP1 gene expression by transcriptional and post-transcriptional mechanisms [35, 36]. As a result, levels of UCP1 mRNA are increased three- to four-fold after just 4 h, and the UCP1 content of mitochondria increase two- to three-fold within four to five days of cold exposure. Both in vivo and in vitro studies indicate a strong synergism between T3- and NE-generated signals in stimulating UCP1 gene transcription, culminating in an approximately eight-fold induction in just a few minutes [38]. The molecular basis of this synergism relies on two functional TREs and a CRE in the UCP1 gene promoter [40]. However, after a few hours of cold exposure, UCP1 gene transcription returns to baseline values and the high levels of UCP1 mRNA during prolonged cold exposure are sustained by a four-fold increase in its half-life, a phenomenon that is also thyroid hormone–dependent [36, 38]. T3 plays an important role in sustaining a higher UCP1 concentration during this post-acute phase of cold exposure, and this T3 effect can be detected even under conditions of minimal sympathetic activity [37]. The normal response of UCP1 to cold exposure is blunted in hypothyroid rats [32, 34, 41] and requires complete saturation of BAT TR [34], as evident from plots of UCP1 levels in BAT mitochondria against TR occupancy during acute treatment of cold-exposed hypothyroid rats with thyroid hormone. From the levels of TR occupancy in hypothyroid animals up to ~70% TR saturation, the response of UCP1 to cold exposure reaches only one-fifth of that observed in euthyroid rats. As TR saturation increases further, however, the UCP1 response is augmented up to the levels seen in cold-exposed euthyroid rats [34]. As with total body O2 consumption, normalizing the UCP1 response with exogenous T3 requires doses that cause systemic hyperthyroidism [31]. In contrast, the same result occurs with only replacement doses of T4. This implies an important role for T4 per se in the response to cold, which is explained by the expression of D2 in BAT. D2-catalyzed T4 5¢ deiodination generates the additional T3 required for adaptive thermogenesis in BAT [22]. Since it is impossible to generate an acute increase in circulating levels of thyroid hormones, the brown adipocytes provide the extra T3 required locally, a process we can term adaptive T3 production. An additional role played by D2 and thyroid hormones in BAT is to mediate the three-to fourfold increase in the activity of lipogenic enzymes, i.e., malic enzyme (ME) and glucose 6-phosphate dehydrogenase (G-6PD), observed in this tissue during cold exposure, a response that is also blunted in hypothyroid rats [34, 42]. T3, in turn, stimulates synthesis of these enzymes, including the expression of Spot-14, a 198 Bianco, Maia, Silva, and Christoffolete lipogenesis-related protein, both in vivo [34, 42] and in differentiating brown adipocytes [43, 44]. During cold exposure, lipogenesis by BAT is a very active pathway, accounting for >50% of the de novo fatty acid synthesis in the rat [45]. BAT lipogenesis is particularly important because it generates the necessary fuel to sustain the high oxidation rate of BAT mitochondria. In freshly isolated brown adipocytes, NE stimulates lipogenesis (determined by incorporation of tritiated water into lipids) and the activity of key lipogenic enzymes, e.g., malic enzyme and acetyl-CoA carboxylase, only in the presence of T4 or TR-saturating concentrations of T3. In the absence of D2 activity, NE markedly inhibits BAT lipogenesis. D2 blockade with iopanoic acid prevents the NE-mediated surge in lipogenesis in the presence of T4, indicating its essential role in this process [46]. THYROID HORMONE IS ESSENTIAL FOR BAT ADAPTIVE THERMOGENESIS, BUT WHY? The lack of a thermal response of BAT to NE infusion in hypothyroid animals was first attributed to the decreased UCP1 levels in these animals [32, 34, 38]. However, subsequent studies found that BAT thermogenesis is restored in T3-treated hypothyroid rats well before UCP1 levels are normalized, indicating that the UCP1 gene is not the limiting locus where adrenergic and thyroid signals interact [33, 47, 48]. Alternatively, it has been proposed that defects in the NE-signaling pathway itself could be involved in limiting BAT adaptive thermogenesis, as hypothyroid rat brown adipocytes have decreased NE responsiveness and generate five- to six-fold less cAMP in response to adrenergic agents [49–51]. Treatment with T3 in vivo restores the adrenergic transduction and BAT thermogenesis in 72 h, but the identity of the T3-dependent gene(s) involved remains unknown [47]. Interestingly, treatment of hypothyroid mice with the GC-1 compound, a TRb-selective agonist, normalizes mitochondrial UCP1 but fails to normalize BAT thermogenesis and cAMP production in response to adrenergic stimulation in vitro, confirming both the poor correlation between UCP1 levels and BAT thermogenesis and the critical role played by the adrenergic transduction mechanisms. A by-product of these studies was the first demonstration that the two TR isoforms, TRb and TRa, are necessary for the full normalization of BAT thermogenesis, Stimulation of UCP1 is mediated by TRb, whereas adrenergic responsiveness is potentiated by TRa [47]. A closer look into the hypothyroid animal model, however, reveals a significant limitation of this model that arises from its inherent increased activity of the SNS. NE turnover in most tissues is accelerated by hypothyroidism, presumably to compensate for the generalized decrease in responsiveness to NE [52]. The increase in the release of NE causes adrenergic desensitization, ultimately decreasing the responsiveness to NE [53, 54]. This phenomenon mitigates the suitability of the hypothyroid animal as a model for investigating thyroid-adrenergic synergism. It is not possible to differentiate clearly between the primary effects of hypothyroidism and desensitization-related events. Even if the studies in hypothyroid animals were performed at thermoneutrality to minimize differences in NE turnover, the results would not be relevant because thermoneutrality is not the physiological temperature at which animals are normally acclimated; the BAT is technically turned off so that the results would reflect thyroidadrenergic synergism when most of the adrenergic component is absent. Deiodination and Energy Expenditure 199 A MOUSE WITH TARGETED DISRUPTION OF THE D2 GENE (DIO2) The recently created mouse with a targeted disruption of the D2 gene (Dio2)/)) constitutes an improved system for studying thyroid-adrenergic interactions [48, 55]. These animals are systemically euthyroid, as their serum T3 level is normal and their serum T4 level is only slightly elevated. Thus, they do not develop homeostatic adaptations at room temperature. However, the absence of D2 impairs BAT thermogenesis by precluding the adaptive increase in T4 to T3 conversion [48]. Non-shivering thermogenesis in BAT is impaired in the Dio2)/) animals, as documented in vivo and in vitro (Fig. 4). When exposed to cold, the Dio2)/) mouse develops hypothermia and survives by increasing shivering thermogenesis. Remarkably, the administration of a single TR-saturating dose of T3 24 h before cold exposure completely restores brown adipocyte function to normality, demonstrating that the critical role of D2 is to catalyze the production of TR-saturating amounts of T3 in these cells [48]. More recently, near-infrared fluorescence imaging was used to confirm that Dio2)/) BAT presents a significant deficiency during cold-induced activation [56]. Thus, contrary to the hypothyroid animal Fig. 4. Adaptive BAT thermogenesis in Dio2)/) (KO) and wild-type (WT) mice: (a) core temperature during cold exposure; (b) temperature changes in intracellular BAT (IBAT) in response to NE infusion; (c) O2 consumption in isolated brown adipocytes. All data are expressed as mean ± SD, n=4–12, *p<0.05 and obtained from (48); (d) near-infrared (NIR) fluorescence imaging of wild-type mice in response to adaptive thermogenesis. Mice were acclimated to 26C and treated with saline (c), CL 316,243 – (1 mg/kg) i.p. (CL+) or norepinephrine – ( 0.3 mg/kg) i.p (NE); (e) same as in d, except that wild-type and knock-out mice were exposed to 4C for 24 h and the NIR signal was quantified. The ordinate shows the BAT-to-background ratio for each condition, n=3; data are mean ± SEM. Modified from [56]. 200 Bianco, Maia, Silva, and Christoffolete model, the Dio2)/) mouse model lends itself to the mechanistic understanding of why D2 is critical for BAT thermogenesis. The analysis of gene expression using microarray technology indicates that the expression of many genes involved in the control of energy expenditure, but not the UCP1 gene, is altered in the Dio2)/) brown adipocytes (Fig. 5). This is critically relevant because the thermogenic mechanisms promoted by D2-generated T3 are thus largely UCP1-independent and likely to operate in other tissues that have a high capacity to transform chemical energy into heat and express D2, such as the skeletal muscle, the main site of adaptive thermogenesis in humans. The non-stimulated Dio2)/) BAT has normal amounts of mitochondria and normal uncoupling UCP1 concentration [48]. Contrary to the hypothyroid animal model, the NE turnover in the Dio2)/) BAT is not increased at room temperature and thus there is no adrenergic desensitization, making the Dio2)/) mouse an ideal system for studying thyroid-adrenergic synergism. Nevertheless, isolated Dio2)/) brown adipocytes displayed impaired cAMP generation, lipolysis, and induction of UCP1 mRNA during incubation with a wide range of NE, CL316,243, and forskolin concentrations, indicating that the absence of D2 makes the Dio2)/) brown adipocytes relatively hypothyroid and insensitive to catecholamine stimulation. To bypass its relative adrenergic insensitivity, the Dio2)/) mouse develops a sustained compensatory increase of approximately nine-fold in BAT SNS stimulation during cold exposure that normalizes the expression of cAMP-dependent genes and metabolic pathways [57]. However, this compensatory mechanism comes with a price tag attached: suppression of the otherwise normal lipogenic surge observed during cold exposure. Thus, this creates a state of metabolic imbalance, rapidly Fig. 5. Maximum binding capacity (MBC), sources of T3, and nuclear T3 receptor occupancy in euthyroid rats during cold acclimation to 4C. Plasma-born T3 is indicated in solid bars and locally produced T3 via D2 is indicated in empty bars. Modified from [15]. Microarray results obtained from BAT RNA of Dio2)/) animals treated with saline or 5 lg of T3 16 h before norepinephrine (NE) treatment. NE (30 lg/100g B.W.) was administered over a 6-h period. The expression data (signal/reference) of NE+T3-treated Dio2)/) animals is shown as plotted against the expression data of NE treated Dio2)/) animals. Eighty-one genes, indicated as open and closed circles, were found to be NE-dependent only when the animals had been treated previously with T3. Differences in gene expression of approximately twofold lie between the two outside lines. Deiodination and Energy Expenditure 201 depleting the brown adipocytes of their source of fatty acids and impairing adaptive thermogenesis [57]. SIGNIFICANCE OF D2 TO ADAPTIVE THERMOGENESIS IN HUMANS The potential role of D2 in human energy homeostasis has been ignored because human newborns grow less dependent on BAT thermogenesis, and adult humans, unlike small mammals, do not have substantial amounts of BAT [58]. However, since the cloning of the human D2 cDNA and the finding of cAMP-inducible D2 mRNA and activity in human skeletal muscle [6, 7], the role of D2 in controlling human adaptive thermogenesis has been revisited. Thyroid hormone per se is known to increase energy expenditure in skeletal muscle [for review 59] and could also regulate local energy homeostasis through its interaction with the SNS. Accordingly, human skeletal muscle is under the influence of the thyroid-adrenergic synergism and an increase in local cAMP production is known to activate glycolytic enzymes, sarcolemmal Na+/K+ pumps, phospholamban, and voltage-sensitive and sarcolemmal Ca++ channels [60, 61], resulting in increased glucose uptake and utilization [62, 63]. The expression of GLUT4, the insulin-responsive-glucose transporter that mediates the rate-limiting step of glucose metabolism in skeletal muscle, is also up-regulated by thyroid hormone [64]. Various studies support a previously unrecognized role of D2 in determining the thyroid status and metabolic rate of the skeletal muscle, analogous to its role in BAT. Earlier experimental studies of humans [65] have consistently found diet-induced changes in serum thyroid hormones that could be explained by changes in D2 activity. As an example, the increase in BMR observed in subjects fed a high carbohydrate diet is typically associated with an increase in the serum T3/T4 ratio [65], a condition that is also observed in adult subjects chronically treated with terbutaline, a b-adrenergic receptor (b-AR) stimulator [8]. This indicates the existence of a relevant cAMP-dependent T4 to T3 conversion pathway in humans that plays a role in energy homeostasis. That this pathway is predominantly through D2 is supported by the finding that the D2 gene is up-regulated severalfold by adrenergic stimulators and cAMP [26]. More recently, studies of patients receiving T4 replacement at various dosages have shown a direct correlation of the BMR with free T4 and inversely with serum TSH but not with serum T3 [9]. Together, these data indicate that D2-produced intracellular T3 in skeletal muscle might be a significant physiological determinant of energy expenditure in humans. Recent studies describing a Dio2 polymorphism in which a threonine (Thr) change to alanine (Ala) at codon 92 (D2 Thr92Ala) provides is additional support to a role of D2 in glucose uptake and utilization. Of note, in humans, skeletal muscle is the primary site of insulin-dependent glucose disposal [66]. Remarkably, this Dio2 polymorphism was associated with an ~20% lower rate of glucose disposal in obese women than in non-obese women [10]. In addition, the frequency of the variant allele was found to be increased in some ethnic groups, such as Pima Indians and MexicanAmericans, with a higher prevalence of insulin resistance [10]. The possible role of the D2 Thr92Ala polymorphism on insulin resistance was also investigated in patients with type 2 diabetes Mellitus (DM2). Studies of these patients offers a practical approach to the investigation of energy expenditure 202 Bianco, Maia, Silva, and Christoffolete because they require intense metabolic monitoring and are subjected to a detailed scrutiny of fuel utilization. In accordance with the previous study in obese individuals, individuals homozygous for the variant allele have an increased insulin-resistance index as assessed by the HOMA (homeostasis model assessment) index. The increased insulin resistance observed in the DM2 patients homozygous for the Ala allele could be explained by a decrease in D2 activity, as has been found in thyroid and skeletal muscle samples from individuals with this genotype [67]. A lower D2 activity would decrease D2-generated T3 in skeletal muscle and create a state of relative intracellular hypothyroidism, decreasing the expression of genes involved in energy utilization, such as GLUT4, leading to insulin resistance. Supporting this hypothesis is the remarkable finding that the UCP1 knock-out mouse develops, as a compensatory mechanism, increased D2 activity in white adipose tissue [68], stressing the importance of understanding the D2-generated T3-dependent thermogenic mechanisms. THYROID HORMONE-DEPENDENT THERMOGENIC MECHANISMS IN SKELETAL MUSCLE Surprisingly little is known about the cellular and molecular mechanisms mediating the increase in energy expenditure by thyroid hormone. Except for the induction of UCP1, which takes place exclusively in BAT [32], the identity of the set of T3-responsive genes that controls energy expenditure is largely unknown. Regardless of their identity, in skeletal muscle these genes probably encode proteins that decrease the efficiency of ATP synthesis and/or increase the turnover rate of biochemical pathways that involve ATP breakdown. Thyrotoxicosis causes mitochondrial uncoupling. In hepatocytes of thyrotoxic rats, approximately 50% of the increase in cellular oxygen consumption was accounted for by an increased rate of mitochondrial H+ leakage [69]. Experiments using JC-1, a mitochondrial membrane potential (DYm) probe, revealed that hepatocytes from rats with different thyroid status present a decrease in the membrane potential and an increase in respiration [70]. In thyrotoxic human skeletal muscle, there is an ~70% increase in the Krebs cycle flux and no increase in ATP synthesis [71]. It is not clear, however, if this T3-induced mitochondrial uncoupling is mediated by increased expression of UCPs. Thyrotoxic rats have increased levels of UCP3 mRNA in skeletal muscle [72]. However, mice with targeted disruption of the UCP3 gene have a normal T3-induced metabolic rate [73]. In addition, the T3-mediated increase in levels of UCP3 mRNA in skeletal muscle could be indirect, resulting from T3-induced lipolysis. Fatty acids are potent stimulators of the UCP3 gene, as its UCP3 mRNA is increased several times in skeletal muscle of fasting animals [74, 75]. It is notable that the turnover of some groups of cyclic reactions that expend relatively large amounts of ATP (involved in the maintenance of ionic and substrate homeostasis), e.g., Na+/K+ transporters in the plasma membrane, is largely inducible by thyroid hormone [76, 77]. This is particularly relevant in skeletal muscle, a large tissue in which a small change in the rate of energy expenditure can impact substantially on the total body thermogenesis. In this tissue, a major thyroid hormone-dependent pathway is the calcium (Ca2+) cycle between cytosol and sarcoplasmic reticulum, which is involved in the contraction and relaxation mech- Deiodination and Energy Expenditure 203 anisms. This cycle consumes a large amount of ATP and is also influenced positively by thyroid hormone [59, 78]. Besides regulating the expression of genes coding for different isoforms of myosin heavy chain (MHC) [79], favoring the expression of isoforms with higher catalytic (ATPase) activity [80], T3 stimulates the expression of the sarcoplasmic endoplasmic reticulum Ca2+ ATPase (SERCA) gene [81–83]. As a result, thyrotoxic muscle has an increased number of SERCA units in the sarcoplasmic reticulum, which increases ATP expenditure even under resting conditions. In addition, at every contraction/relaxation cycle, the amount of Ca2+ mobilized is larger and, consequently, so is the ATP expenditure. More recently, it has demonstrated that thyroid hormone increases the Ca2+-ATPase uncoupled activity, i.e., the activity from ATP hydrolysis that does not result in the accumulation of Ca2+ inside the sarcoplasmic reticulum [84, 85]. Consequently, more chemical energy is dissipated into heat. This uncoupled Ca2+-ATPase activity has been shown to be higher for SERCA 1 than for SERCA 2 isoform. Thus, it is notable that thyroid hormone upregulates SERCA 1 gene expression in skeletal muscle [86]. In addition to the Ca2+ cycles, a number of similar cycles involving other ions, metabolic intermediates, and energy substrates (substrate cycles) are influenced by thyroid hormone, e.g., fructose 6-phosphate/fructose 1,6-bisphosphate, Cori cycle, lipolysis/lipogenesis [87], glycogenolysis/glycogenesis, proteolysis/protein synthesis, bone formation and resorption [88], and others. It is important to stress that the stimulation of the turnover of these cycles changes the sizes of the pools of substrates involved very little, depending on the intensity and duration of the stimulus. However, all increase the expenditure of ATP expenditure, the metabolic rate, and, therefore, heat production. These data, in summary, suggest that the intracellular concentration of T3 is an important determinant of coupling between energy supply and demand. Finally, it would not be surprising if no single mechanism were responsible for the T3-induced increase in ATP turnover, BMR, and heat production. The final thermogenic effects of T3 would represent the sum total of small effects spread throughout the metabolic pathways that increase synthesis and hydrolysis of ATP. The complexity of the T3 action has been proposed as a good model for the top-down elasticity analysis of energy metabolism [89] as a tentative approach to identify different sites of action of effectors of the energy turnover. ACKNOWLEDGMENT NIH grants DK58538 and DK65655. PEW charitable trusts foundation fellowship to WSS. REFERENCES 1. Oppenheimer, J. H., Schwartz, H. L., Mariash, C. N., Kinlaw, W. B., Wong, N. C. W., and Freake, H. C. (1987) Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8:288–308. 2. Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., and Larsen, P. R. (2002) Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23:38–89. 204 Bianco, Maia, Silva, and Christoffolete 3. Silva, J. E. and Larsen, P. R. (1986) Regulation of thyroid hormone expression at the prereceptor and receptor levels. In: Thyroid Hormone Metabolism (G. Hennermann, eds.), Marcel Dekker, Inc, New York and Basel, pp. 441–500. 4. Kalaany, N., Gauthier, K., and Mangelsdorf, D. (2004) Linking LXRs to diet-induced obesity. In: Nuclear Receptors; Orphan Brothers. Keystone, Colorado. 76. 5. Watanabe, M., Houten, S. M., C., M., and J, A., (2004). Bile acids induce energy expenditure in brown adipose tissue and ameliorate insulin sensitivity. In: Diabetes Mellitus: Molecular Signaling, Genes and Therapeutics and Molecular Control of Adipogenesis and Obesity. Banff. 71. 6. Salvatore, D., Bartha, T., Harney, J. W., and Larsen, P. R. (1996) Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308–3315. 7. Croteau, W., Davey, J. C., Galton, V. A., and St Germain, D. L. (1996) Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J. Clin. Invest. 98:405–417. 8. Scheidegger, K., O’Connell, M., Robbins, D. C., and Danforth, E. Jr. (1984) Effects of chronic betareceptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones. J. Clin. Endocrinol. Metab. 58:895–903. 9. Al-Adsani, H., Hoffer, L. J., and Silva, J. E. (1997) Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J. Clin. Endocrinol. Metab. 82:1118–1125. 10. Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., and Celi, F. S. (2002) Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3adrenergic receptor. Diabetes 51:880–883. 11. Silva, J. E. and Larsen, (1977) Pituitary nuclear 3,5,3¢-triiodothyronine and thyrotropin secretion explanation for the effect of thyroxine. Science 198:617–620. 12. Silva, J. E., Leonard, J. L., Crantz, F. R., and Larsen, P. R. (1982) Evidence for two tissue- specific pathways for in vivo thyroxine 5¢- deiodination in the rat. J. Clin. Invest. 69:1176–1184. 13. Silva, J. E., Dick, T. E., and Larsen, P. R. (1978) The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3¢-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103:1196–1207. 14. Silva, J. E. and Larsen, P. R. (1978) Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid- stimulating hormone release. J. Clin. Invest. 61:1247–1259. 15. Bianco, A. C. and Silva, J. E. (1987) Nuclear 3,5,3¢-triiiodothyronine (T3) in brown adipose tissue: receptor occupancy and sources of T3 as determined by in vivo techniques. Endocrinology 120:55–62. 16. Baqui, M. M., Gereben, B., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2000) Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141:4309–4312. 17. Wassen, F. W., Schiel, A. E., Kuiper, G. G., Kaptein, E., Bakker, O., Visser, T. J., and Simonides, W. S. (2002) Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143:2812–2815. 18. Silva, J. E. (1995) Thyroid hormone control of thermogenesis and energy balance. Thyroid 5:481–492. 19. Heaton, G. M., Wagenvoord, R. J., Kemp, A., Nicholls, D. G. (1978) Brown-adipose-tissue mitochondria: photoaffinity labelling of the regulatory site of energy dissipation. Eur. J. Biochem. 82:515– 521. 20. Ricquier, D., Lin, C., and Klingenberg, M. (1982) Isolation of the GDP binding protein from brown adipose tissue mitochondria of several animals and amino acid composition study in rat. Biochem. Biophys. Res. Commun. 106:582–589. 21. Enerback, S., Jacobsson, A., Simpson, E. M., Guerra, C., Yamashita, H., Harper, M. E., and Kozak, L. P. (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387:90–94. 22. Silva, J. E. and Larsen, P. R. (1983) Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature 305:712–713. Deiodination and Energy Expenditure 205 23. Obregon, M. J., Mills, I., Silva, J. E., and Larsen, P. R. (1987) Catecholamine stimulation of iodothyronine 5¢-deiodinase activity in rat dispersed brown adipocytes. Endocrinology 120:1069–1072. 24. Raasmaja, A. and Larsen, P. R. (1989) Alpha 1- and beta-adrenergic agents cause synergistic stimulation of the iodothyronine deiodinase in rat brown adipocytes. Endocrinology 125:2502–2509. 25. Mills, I., Raasmaja, A., Moolten, N., Lemack, G., Silva, J. E., and Larsen, P. R. (1989) Effect of thyroid status on catecholamine stimulation of thyroxine 5¢- deiodinase in brown adipocytes. Am. J. Physiol. 256:E74–79. 26. Bartha, T., Kim, S. W., Salvatore, D., Gereben, B., Tu, H. M., Harney, J. W., Rudas, P., and Larsen, P. R. (2000) Characterization of the 5¢-flanking and 5¢-untranslated regions of the cyclic adenosine 3¢,5¢-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 141:229–237. 27. Curcio-Morelli, C., Zavacki, A. M., Christofollete, M., Gereben, B., Freitas, B. C. G., Harney, J. W., Li, Z., Wu, G., and Bianco, A. C. (2003) Deubiquitination of type 2 iodothyronine deiodinase by pVHL-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112:189–196. 28. Silva, J. E. and Larsen, P. R. (1985) Potential of brown adipose tissue type II thyroxine 5¢-deiodinase as a local and systemic source of triiodothyronine in rats. J. Clin. Invest. 76:2296–2305. 29. Bianco, A. C. and Silva, J. E. (1988) Cold exposure rapidly induces virtual saturation of brown adipose tissue nuclear T3 receptors. Am. J. Physiol. 255:E496–E503. 30. Silva, J. E., Dick, T. E., and Larsen, P. R. (1978) Contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3¢-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103:1196–1207. 31. Carvalho, S. D., Kimura, E. T., Bianco, A. C., and Silva, J. E. (1991) Central role of brown adipose tissue thyroxine 5¢-deiodinase on thyroid hormone-dependent thermogenic response to cold . Endocrinology 128:2149–2159. 32. Bianco, A. C. and Silva, J. E. (1987) Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J Clin. Invest. 79:295–300. 33. Ribeiro, M. O., Lebrun, F. L., Christoffolete, M. A., Branco, M., Crescenzi, A., Carvalho, S. D., Negrao, N., and Bianco, A. C. (2000) Evidence of UCP1-independent regulation of norepinephrineinduced thermogenesis in brown fat. Am. J. Physiol. Endocrinol. Metab. 279:E314–322. 34. Bianco, A. C. and Silva, J. E. (1987) Optimal response of key enzymes and uncoupling protein to cold in BAT depends on local T3 generation. Am. J. Physiol. 253:E255–E263. 35. Bianco, A. C., Sheng, X., and Silva, J. E. (1988) Triiodothyronine amplifies norepinephrine stimulation of uncoupling protein gene transcription by a mechanism not requiring protein synthesis. J. Biol. Chem. 263:18168–18175. 36. Rehnmark, S., Bianco, A. C., Kieffer, J. D., and Silva, J. E. (1992) Transcriptional and posttranscriptional mechanisms in uncoupling protein mRNA response to cold. Am. J. Physiol. 262:E58–E67. 37. Branco, M., Ribeiro, M., Negrao, N., and Bianco, A. C. (1999) 3,5,3¢-Triiodothyronine actively stimulates UCP in brown fat under minimal sympathetic activity. Am. J. Physiol. 276:E179–E187. 38. Bianco, A. C., Kieffer, J. D., and Silva, J. E. (1992) Adenosine 3¢,5¢-monophosphate and thyroid hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown adipocytes. Endocrinology 130:2625–2633. 39. Hernandez, A. and Obregon, M. J. (2000) Triiodothyronine amplifies the adrenergic stimulation of uncoupling protein expression in rat brown adipocytes. Am. J. Physiol. Endocrinol. Metab. 278:E769–777. 40. Silva, J. E. and Rabelo, R. (1997) Regulation of the uncoupling protein gene expression. Eur. J. Endocrinol. 136:251–264. 41. Obregon, M. J., Pitamber, R., Jacobsson, A., Nedergaard, J., and Cannon, B. (1987) Euthyroid status is essential for the perinatal increase in thermogenin mRNA in brown adipose tissue of rat pups. Biochem. Biophys. Res. Commun. 148:9–14. 42. Carvalho, S. D., Negrao, N., and Bianco, A. C. (1993) Hormonal regulation of malic enzyme and glucose-6-phosphate dehydrogenase in brown adipose tissue. Am. J. Physiol. 264:E874–E881. 43. Perez-Castillo, A., Hernandez, A., Pipaon, C., Santos, A., and Obregon, M. J. (1993) Multiple regulation of S14 gene expression during brown fat differentiation. Endocrinology 133:545–552. 206 Bianco, Maia, Silva, and Christoffolete 44. Garcia-Jimenez, C., Hernandez, A., Obregon, M. J., and Santisteban, P. (1993) Malic enzyme gene expression in differentiating brown adipocytes: regulation by insulin and triiodothyronine. Endocrinology 132:1537–1543. 45. McCormack, J. G. (1982) The regulation of fatty acid synthesis in brown adipose tissue by insulin Prog. Lipid. Res. 21:195–223. 46. Bianco, A. C., Carvalho, S. D., Carvalho, C. R., Rabelo, R., and Moriscot, A. S. (1998) Thyroxine 5¢deiodination mediates norepinephrine-induced lipogenesis in dispersed brown adipocytes. Endocrinology 139:571–578. 47. Ribeiro, M. O., Carvalho, S. D., Schultz, J. J., Chiellini, G., Scanlan, T. S., Bianco, A. C., and Brent, G. A. (2001) Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J. Clin. Invest. 108:97–105. 48. de Jesus, L. A., Carvalho, S. D., Ribeiro, M. O., Schneider, M., Kim, S.-W., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Invest. 108:1379–1385. 49. Rubio, A., Raasmaja, A., and Silva, J. E. (1995) Thyroid hormone and norepinephrine signaling in brown adipose tissue. II: Differential effects of thyroid hormone on beta 3-adrenergic receptors in brown and white adipose tissue. Endocrinology 136:3277–3284. 50. Rubio, A., Raasmaja, A., Maia, A. L., Kim, K. R., and Silva, J. E. (1995) Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 3¢,5¢-monophosphate generation. Endocrinology 136:3267–3276. 51. Carvalho, S. D., Bianco, A. C., and Silva, J. E. (1996) Effects of hypothyroidism on brown adipose tissue adenylyl cyclase activity. Endocrinology 137:5519–5529. 52. Young, J. B., Saville, E., and Landsberg, L. (1982) Effect of thyroid state on norepinephrine (NE) turnover in rat brown adipose tissue (BAT): potential importance of the pituitary. Gin. Res. 32:407Abstract. 53. Himms-Hagen, J. (1990) Brown adipose tissue thermogenesis: interdisciplinary studies Faseb. J. 4:2890–2898. 54. Jockers, R., Issad, T., Zilberfarb, V., de Coppet, P., Marullo, S., and Strosberg, A. D. (1998) Desensitization of the {beta} -Adrenergic Response in Human Brown Adipocytes. Endocrinology 139:2676–2684. 55. Schneider, M. J., Fiering, S. N., Pallud, S. E., Parlow, A. F., St. Germain, D. L., and Galton, V. A. (2001) Targeted disruption of the type 2 selenodeiodinase gene (Dio2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137–2148. 56. Nakayama, A., Bianco, A. C., Zhang, C. Y., Lowell, B. B., and Frangioni, J. V (2003) Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Mol. Imaging. 2:37–49. 57. Christoffolete, M. A., Linardi, C. C. G., de Jesus, L. A., Ebina, K. N., Carvalho, S. D., Ribeiro, M. O., Rabelo, R., Curcio, C., Martins, L., and Kimura, E. T., et al. (2004) Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of uncoupling protein 1 gene but fail to increase brown adiose tissue lipogenesis and adaptive thermogenesis. Diabetes 53:577–584. 58. Bruck, K. (1998) Neonatal thermal regulation. In: Fetal and Neonatal Physiology (R. A. Polin, and W. W. Fox, eds.), W. B. Saunders Co, Philadelphia, pp. 676–702. 59. De Meis, L. (2001) Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis Biosci. Rep. 21:113–137. 60. Yang, Y. T. and McElligott, M. A. (1989) Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue. Biochem. J. 261:1–10. 61. Roberts, S. J. and Summers, R. J. (1998) Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors. Eur. J. Pharmacol. 348:53–60. 62. McCarter, F. D., James, J. H., Luchette, F. A., Wang, L., Friend, L. A., King, J. K., Evans, J. M., George, M. A, and Fischer, J. E. (2001) Adrenergic blockade reduces skeletal muscle glycolysis and Na(+), K(+)- ATPase activity during hemorrhage. J. Surg. Res. 99:235–244. 63. Fryer, L. G., Foufelle, F., Barnes, K., Baldwin, S. A., Woods, A., and Carling, D. (2002) Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells . Biochem. J. 363:167–174. 64. Ezaki, O. (1997) Regulatory elements in the insulin-responsive glucose transporter (GLUT4) gene Biochem. Biophys. Res. Commun. 241:1–6. Deiodination and Energy Expenditure 207 65. Danforth, J. E., Horton, E. S., and O’Connell, M., et al. (1979) Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J. Clin. Invest. 64:1336–1347. 66. Ferrannini, E., Galvan, A. Q., Gastaldelli, A., Camastra, S., Sironi, A. M., Toschi, E., Baldi, S., Frascerra, S., Monzani, F., and Antonelli, A., et al. (1999) Insulin: new roles for an ancient hormone. Eur J Clin Invest 29:842–852. 67. Canani, L. H., Capp, C., Dora, J. M., Meyer, E., Harney, J. W., Larsen, P. R., Gross, J. L., Bianco, A. C., and Maia, A. L. (2005) Type 2 Deiodinase Thr92Ala Polymorphism is associated with decreased enzyme velocity and severe insulin resistance in Type 2 diabetes mellitus patients. J. Clin. Endocrinol. Metab. (in press). 68. Liu, X., Rossmeisl, M., McClaine, J., Riachi, M., Harper, M. E., and Kozak, L. P. (2003) Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J. Clin. Invest. 111:399–407. 69. Harper, M. E. and Brand, M. D. (1993) The quantitative contributions of mitochondrial proton leak and ATP turnover reactions to the changed respiration rates of hepatocytes from rats of different thyroid status. J. Biol. Chem. 268:14850–14860. 70. Bobyleva, V., Pazienza, T. L., Maseroli, R., Tomasi, A., Salvioli, S., Cossarizza, A., Franceschi, C., and Skulachev, V. P. (1998) Decrease in mitochondrial energy coupling by thyroid hormones: a physiological effect rather than a pathological hyperthyroidism consequence. FEBS. Lett. 430:409– 413. 71. Lebon, V., Dufour, S., Petersen, K. F., Ren, J., Jucker, B. M., Slezak, L. A., Cline, G. W., Rothman, D. L., and Shulman, G. I. (2001) Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J. Clin. Invest. 108:733–737. 72. Gong, D. W., He, Y., Karas, M., and Reitman, M. (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J. Biol. Chem. 272:24129–24132. 73. Gong, D. W., Monemdjou, S., Gavrilova, O., Leon, L. R., Marcus-Samuels, B., Chou, C. J., Everett, C., Kozak, L. P., Li, C., and Deng, C., et al. (2000) Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J. Biol. Chem. 275:16251–16257. 74. Aubert, J., Champigny, O., Saint-Marc, P., Negrel, R., Collins, S., Ricquier, D., and Ailhaud, G. (1997) Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochem. Biophys. Res. Commun. 238:606–611. 75. Brun, S., Carmona, M. C., Mampel, T., Vinas, O., Giralt, M., Iglesias, R., and Villarroya, F. (1999) Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 48:1217–1222. 76. Desai-Yajnik, V., Zeng, J., Omori, K., Sherman, J., and Morimoto, T. (1995) The effect of thyroid hormone treatment on the gene expression and enzyme activity of rat liver sodium-potassium dependent adenosine triphosphatase. Endocrinology 136:629–639. 77. Folke, M. and Sestoft, L. (1977) Thyroid calorigenesis in isolated, perfused rat liver: minor role of active sodium-potassium transport. J. Physiol. 269:407–419. 78. Reis, M., Farage, M., and de Meis, L. (2002) Thermogenesis and energy expenditure: control of heat production by the Ca(2+)-ATPase of fast and slow muscle. Mol. Membr. Biol. 19:301–310. 79. Izumo, S., Nadal-Ginard, B., and Mahdavi, V. (1986) All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231:597–600. 80. Canepari, M., Cappelli, V., Pellegrino, M. A., Zanardi, M. C., and Reggiani, C. (1998) Thyroid hormone regulation of MHC isoform composition and myofibrillar ATPase activity in rat skeletal muscles. Arch. Physiol. Biochem. 106:308–315. 81. Nunes, M. T., Bianco, A. C., Migala, A., Agostini, B., and Hasselbach, W. (1985) Thyroxine induced transformation in sarcoplasmic reticulum of rabbit soleus and psoas muscles. Z. Naturforsch [C] 40:726–734. 82. Sayen, M. R., Rohrer, D. K., and Dillmann, W. H. (1992) Thyroid hormone response of slow and fast sarcoplasmic reticulum Ca2+ ATPase mRNA in striated muscle. Mol. Cell. Endocrinol. 87:87–93. 83. Simonides, W. S., Thelen, M. H., van der Linden, C. G., Muller, A., and van Hardeveld, C. (2001) Mechanism of thyroid-hormone regulated expression of the SERCA genes in skeletal muscle: implications for thermogenesis. Biosci. Rep. 21:139–154. 208 Bianco, Maia, Silva, and Christoffolete 84. Arruda, A. P., Da-Silva, W. S., Carvalho, D. P., and De Meis, L. (2003) Hyperthyroidism increases the uncoupled ATPase activity and heat production by the sarcoplasmic reticulum Ca2+-ATPase. Biochem. J. 375:753–760. 85. de Meis, L., Arruda, A. P., da-Silva, W. S., Reis, M., and Carvalho, D. P. (2003) The thermogenic function of the sarcoplasmic reticulum Ca2+-ATPase of normal and hyperthyroid rabbit. Ann. N. Y. Acad. Sci. 986:481–488. 86. Simonides, W. S., Brent, G. A., Thelen, M. H., van der Linden, C. G., Larsen, P. R., and van Hardeveld, C. (1996) Characterization of the promoter of the rat sarcoplasmic endoplasmic reticulum Ca2+-ATPase 1 gene and analysis of thyroid hormone responsiveness. J. Biol. Chem. 271:32048– 32056. 87. Oppenheimer, J. H., Schwartz, H. L., Lane, J. T., and Thompson, M. P. (1991) Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis. J. Clin. Invest. 87:125– 132. 88. Gouveia, C. H., Jorgetti, V., and Bianco, A. C. (1997) Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats. J. Bone. Miner. Res. 12:2098–2107. 89. Brand, M. D. (1998) Top-down elasticity analysis and its application to energy metabolism in isolated mitochondria and intact cells. Mol. Cell Biochem. 184:13–20. 90. Baqui, M. M., Botero, D., Gereben, B., Curcio, C., Harney, J. W., Salvatore, D., Sorimachi, K., Larsen, P. R., and Bianco, A. C. (2003) Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J. Biol. Chem. 278:1206–1211.